208 related articles for article (PubMed ID: 26708472)
1. Specific antitumour immunity of HIFU-activated cytotoxic T lymphocytes after adoptive transfusion in tumour-bearing mice.
Ran LF; Xie XP; Xia JZ; Xie FL; Fan YM; Wu F
Int J Hyperthermia; 2016; 32(2):204-10. PubMed ID: 26708472
[TBL] [Abstract][Full Text] [Related]
2. High-intensity focused ultrasound tumor ablation activates autologous tumor-specific cytotoxic T lymphocytes.
Xia JZ; Xie FL; Ran LF; Xie XP; Fan YM; Wu F
Ultrasound Med Biol; 2012 Aug; 38(8):1363-71. PubMed ID: 22633269
[TBL] [Abstract][Full Text] [Related]
3. T-lymphocytes from focused ultrasound ablation subsequently mediate cellular antitumor immunity after adoptive cell transfer immunotherapy.
Ran LF; Xie XP; Xia JZ; Xie FL; Fan YM; Wu F
Front Immunol; 2023; 14():1155229. PubMed ID: 37564660
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells loaded with ultrasound-ablated tumour induce in vivo specific antitumour immune responses.
Deng J; Zhang Y; Feng J; Wu F
Ultrasound Med Biol; 2010 Mar; 36(3):441-8. PubMed ID: 20172447
[TBL] [Abstract][Full Text] [Related]
5. Effector cells of low-dose IL-2 immunotherapy in tumor bearing mice: tumor cell killing by CD8+ cytotoxic T lymphocytes and macrophages.
Maas RA; Roest PA; Becker MJ; Weimar IS; Dullens HF; Den Otter W
Immunobiology; 1992 Nov; 186(3-4):214-29. PubMed ID: 1490728
[TBL] [Abstract][Full Text] [Related]
6. Anti-idiotype antibody induced cellular immunity in mice transgenic for human carcinoembryonic antigen.
Saha A; Chatterjee SK; Foon KA; Bhattacharya-Chatterjee M
Immunology; 2006 Aug; 118(4):483-96. PubMed ID: 16895556
[TBL] [Abstract][Full Text] [Related]
7. Investigation of HIFU-induced anti-tumor immunity in a murine tumor model.
Hu Z; Yang XY; Liu Y; Sankin GN; Pua EC; Morse MA; Lyerly HK; Clay TM; Zhong P
J Transl Med; 2007 Jul; 5():34. PubMed ID: 17625013
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of antitumor vaccine in ablated hepatocellular carcinoma by high-intensity focused ultrasound.
Zhang Y; Deng J; Feng J; Wu F
World J Gastroenterol; 2010 Jul; 16(28):3584-91. PubMed ID: 20653069
[TBL] [Abstract][Full Text] [Related]
9. Adoptive transfer of cytotoxic T-cells for treatment of residual disease after irradiation.
Krause M; Schmitz M; Noessner E; Skrablin PS; Wehner R; Rieber EP; Baumann M
Int J Radiat Biol; 2007; 83(11-12):827-36. PubMed ID: 17852560
[TBL] [Abstract][Full Text] [Related]
10. M-HIFU inhibits tumor growth, suppresses STAT3 activity and enhances tumor specific immunity in a transplant tumor model of prostate cancer.
Huang X; Yuan F; Liang M; Lo HW; Shinohara ML; Robertson C; Zhong P
PLoS One; 2012; 7(7):e41632. PubMed ID: 22911830
[TBL] [Abstract][Full Text] [Related]
11. Targeting spatiotemporal expression of CD137 on tumor-infiltrating cytotoxic T lymphocytes as a novel strategy for agonistic antibody therapy.
Noji S; Hosoi A; Takeda K; Matsushita H; Morishita Y; Seto Y; Kakimi K
J Immunother; 2012 Jul; 35(6):460-72. PubMed ID: 22735804
[TBL] [Abstract][Full Text] [Related]
12. Autolymphocyte therapy--I. In vivo tumour-specific adoptive cellular therapy of murine melanoma and carcinoma using ex vivo activated memory T-lymphocytes.
Gold JE; Osband ME
Eur J Cancer; 1994; 30A(12):1871-82. PubMed ID: 7880620
[TBL] [Abstract][Full Text] [Related]
13. Synergistic enhancement of antitumor immunity with adoptively transferred tumor-specific CD4+ and CD8+ T cells and intratumoral lymphotactin transgene expression.
Huang H; Li F; Gordon JR; Xiang J
Cancer Res; 2002 Apr; 62(7):2043-51. PubMed ID: 11929823
[TBL] [Abstract][Full Text] [Related]
14. Increased infiltration of activated tumor-infiltrating lymphocytes after high intensity focused ultrasound ablation of human breast cancer.
Lu P; Zhu XQ; Xu ZL; Zhou Q; Zhang J; Wu F
Surgery; 2009 Mar; 145(3):286-93. PubMed ID: 19231581
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy of cancer via mediation of cytotoxic T lymphocytes by methionine enkephalin (MENK).
Li W; Chen W; Herberman RB; Plotnikoff NP; Youkilis G; Griffin N; Wang E; Lu C; Shan F
Cancer Lett; 2014 Mar; 344(2):212-22. PubMed ID: 24291668
[TBL] [Abstract][Full Text] [Related]
16. Bryostatin 1/ionomycin (B/I) ex vivo stimulation preferentially activates L-selectinlow tumor-sensitized lymphocytes.
Chin CS; Miller CH; Graham L; Parviz M; Zacur S; Patel B; Duong A; Bear HD
Int Immunol; 2004 Sep; 16(9):1283-94. PubMed ID: 15262898
[TBL] [Abstract][Full Text] [Related]
17. Successful adoptive cellular immunotherapy is dependent on induction of a host immune response triggered by cytokine (IFN-gamma and granulocyte/macrophage colony-stimulating factor) producing donor tumor-infiltrating lymphocytes.
Nagoshi M; Goedegebuure PS; Burger UL; Sadanaga N; Chang MP; Eberlein TJ
J Immunol; 1998 Jan; 160(1):334-44. PubMed ID: 9551989
[TBL] [Abstract][Full Text] [Related]
18. Fate and function of anti-CD3/CD28-activated T cells following adoptive transfer: IL-2 promotes development of anti-tumor memory T cells in vivo.
Hughes DP; Baskar D; Urban FF; Friedman MS; Braun TM; McDonagh KT
Cytotherapy; 2005; 7(5):396-407. PubMed ID: 16236629
[TBL] [Abstract][Full Text] [Related]
19. Transfer of in vitro expanded T lymphocytes after activation with dendritomas prolonged survival of mice challenged with EL4 tumor cells.
Li J; Theofanous L; Stickel S; Bouton-Verville H; Burgin KE; Jakubchak S; Wagner TE; Wei Y
Int J Oncol; 2007 Jul; 31(1):193-7. PubMed ID: 17549421
[TBL] [Abstract][Full Text] [Related]
20. Adoptive cytotoxic T lymphocyte therapy triggers a counter-regulatory immunosuppressive mechanism via recruitment of myeloid-derived suppressor cells.
Hosoi A; Matsushita H; Shimizu K; Fujii S; Ueha S; Abe J; Kurachi M; Maekawa R; Matsushima K; Kakimi K
Int J Cancer; 2014 Apr; 134(8):1810-22. PubMed ID: 24150772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
